Historically there have been no widely accepted methods by which to evaluate the quality of radiation oncology research programmes. Between…
Driving collaboration in radiotherapy research through the STFC Global Challenge Network+
'In this blog post, Karen Kirkby, Professor of Proton Therapy Physics at the University of Manchester and The Christie NHS…
The journey of TORPEdO – the UK’s first proton beam therapy clinical trial
'Dr David Thomson, Consultant Clinical Oncologist at The Christie Hospital in Manchester is the Chief Investigator for the TORPEdO (TOxicity…
Celebrating ten years of NCRI’s Clinical and Translational Radiotherapy Research Group
'NCRI’s Radiotherapy Research Group (CTRad) is one of NCRI’s flagship initiatives and this June we are celebrating its ten year…
Prof Mererid Evans appointed NCRI CTRad Deputy Chair
'We are pleased to announce that, following an open competitive recruitment process, Prof Mererid Evans has been appointed as NCRI…
Developing the UK research strategy for Proton Beam Therapy
'Thanks to a £250m investment from the UK government, the first of two NHS Proton Beam Therapy (PBT) centres has…
Patients with low risk thyroid cancer can receive lower doses of radiation treatment
'Thyroid cancer patients whose disease is at low risk of returning can be treated safely with a smaller amount of…
UK contribution to global radiotherapy research shines out in recent review
'To mark the 150th birthday of Marie Curie, the ‘Godmother of Radiotherapy’, NCRI’s Radiotherapy Research Group (CTRad) reviewed key practice…
Developing a consensus for the future of radiotherapy-drug research
'Despite increasing numbers of radiotherapy trials and rising recruitment, a continuing challenge has been increasing the number of trials evaluating…
Developing better cancer trials for non-small cell lung cancers
'A consortium established by NCRI CTRad and the NCRI Lung Group to address the lack of radiotherapy and drug combination…
CTRad: moving boldly into the next phase 2018-2021
'Since its inception in 2009, NCRI’s flagship radiotherapy initiative, the Clinical and Translational Radiotherapy Research Working Group (CTRad), has achieved…
Identifying more harm than good: The PRIMETIME breast cancer study
'PRIMETIME is a research study in early breast cancer investigating whether it’s possible to identify a group of women with…